(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

MH MOLECULAR HEALTH

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

MH MOLECULAR HEALTH

ST13

US500000087048078

Classe

9, 35, 36, 38, 42, 44

Pedido

87048078

Registro

6420058

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

61

Atualização mais recente

13/07/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

9, 35, 36, 38, 42, 44

Data de depósito

24/05/2016

Data de registro

13/07/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

13/07/2021

Última transação

13/07/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

01/11/2019

Primeiro uso no comércio

01/11/2019

Código do desenho

3

Tipo de titular

99

Localização do titular

Heidelberg, DE

Examinador

HISER, CHARLES

Unidade examinadora

O20

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of the word "MOLECULAR" above the word "HEALTH", to the right of"MH", the "MH" being in stylized lettering consisting of elongated vertical shapes.

Titulares e representantes

Titulares

Molecular Health GmbH

Representantes

Peter T. Wakiyama Troutman Pepper Hamilton Sanders LLP

Classificação técnica

Classes Nice

Classe 9Classe 35Classe 36Classe 38Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Downloadable computer databases containing information in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticalslife sciences and biotechnology; downloadable computer databases containing medical and health information or records about or relating to humans; downloadable computer software for accessingorganizingindexingrankingintegratinglinkingreferencingsynthesizinginterpreting and analyzing information from databases in the fields of medicinehealth caregenomicspharmaceuticalslife sciences and biotechnology and databases containing medical and health information or records about or relating to humansincluding biomedical databases containing information about clinicalgenomicmolecularscientific and patient specific datain particular information that clinicians and researchers enable to interpret complex molecular and genomic patient information; downloadable computer databases in the field of biomedical informationin particular links to external reference databasesin particular for the alignment and integration of biomedical information; downloadable computer software and algorithms for storing and sorting biomedical informationin particular links to external reference databasesin particular for the alignment and integration of biomedical informationupdating and expanding global reference data sources across diverse medical disciplines and for allowing the immediate access to biomedical information; downloadable computer databases containing biomedical information in form of human genome sequencesinformation about indication and classifications of diseasesbiomarkersinformation about the molecular mechanism of action of drugstheir targetsmetabolizing enzymesinformation about scientific publications from diverse areas of biomedicine drug-to-drug interactions and the status of drug development; downloadable computer software and algorithms for authorizing or providing access to biomedical databasesin particular application softwareinterface softwaresoftware drivesdata communication softwareinteractive computer software; downloadable computer software and software components for serving domain-specific user demands; downloadable mobile applications for mobile devicessuch as smart phones and tablet computersfor accessingorganizingsynthesizingindexingrankingintegratinglinkingreferencinginterpreting and analyzing information from databases in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticalslife sciences and biotechnology and databases containing medical and health information or records about or relating to humans

Classe 35

Business consulting and research services for employers in the field of employee benefits in the nature of offering medical and health care plans to employees and their family members and domestic partners for medical and health care diagnostic and treatment support programs

Classe 36

Financial administration of programs and services for payment and reimbursement of employee benefits in the nature of medical and health care diagnostic and treatment support programsfor employees and their family members and domestic partners

Classe 38

Providing access to searchable databases containing medicalpharmaceuticalbiologicalclinical and genomic information and medical and health information or recordsmolecular test results and patient specific data about or relating to humans for scientific research purposes; providing access to non-downloadable computer software and algorithms for use by physiciansclinicians and other healthcare professionalslaboratory personnelconsultantsscientists and other researchers for medical diagnostic and treatment and drug safety research and drug or pharmaceuticals or other treatment discoveryresearch and development; providing access to non-downloadable software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment research and drug or pharmaceuticals or other treatment discoveryresearch and development purposes; providing access to non-downloadable computer software and algorithms for use by physiciansclinicians and other healthcare professionalslaboratory personnelconsultantsscientists and other researchers for medical diagnostic and treatment purposes; providing access to software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes; providing access to databases containing medicalpharmaceuticalbiologicalclinicalmolecularsequencing and genomic informationdisease informationbiomarker information and medical or health information or records about or relating to humans and patient specific datamolecular test resultsscientific research for medical diagnostic and treatment purposes

Classe 42

Scientific consulting and research services in the fields of health caremedicinelife sciencesbiotechnologypharmaceuticalsbioinformaticsgenomics and pharmaceuticals and pharmaceutical safety for scientific research purposes; Scientific consulting and research services for the retrievalintegrationcorrelationanalysis and interpretation of genomic datasequencing datamolecular datadiseasebiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment research and drug or pharmaceuticals or other treatment discoveryresearch and development purposes; designing and developing and providing temporary use of online searchable databases containing medicalpharmaceuticalbiologicalclinical and genomic information and medical and health information or recordsmolecular test results and patient specific data about or relating to humans for scientific research purposes; designing and developing and providing temporary use of non-downloadable computer software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular data and information on diseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationpatient specific datamolecular test resultsdata from clinical studiesscientific research for use by physiciansclinicians and other healthcare professionalslaboratory personnelconsultantsscientists and other researchers for medical diagnostic and treatment and drug safety research and drug or pharmaceuticals or other treatment discoveryresearch and development; designing and developing and providing temporary use of non-downloadable software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment research and drug or pharmaceuticals or other treatment discoveryresearch and development purposes; software as a Service (SaaS) used in research and consulting for enabling the retrievalintegrationcorrelationanalysis and interpretation of genomic datasequencing data and molecular datadisease informationbiomarker informationdrug protocolsdrug interactionsclinical profilespatient specific datamolecular test resultsdata from clinical studiesscientific research and health and medical informationrecords or data for medicaldiagnostic and treatment and drug safety research and drug or pharmaceuticals or other treatment discoveryresearch and development purposes; provision of non-downloadable mobile applications for mobile devicessuch as smart phones and tabletsnon-downloadable web applications accessible through the Internet for accessing databases in the fields of medicinehealth caregenomicsbioinformaticspharmaceuticals and pharmaceutical safetylife sciences and biotechnology; data collection services for scientific research purposes in the fields of genomicshealth carepharmaceuticalslife sciencesbioinformaticsbiotechnology and medicine; scientific research services for the retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes; providing temporary use of non-downloadable computer software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular data and information on diseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationpatient specific datamolecular test resultsdata from clinical studiesscientific research for use by physiciansclinicians and other healthcare professionalslaboratory personnelconsultantsscientists and other researchers for medical diagnostic and treatment purposes; providing temporary use of non-downloadable software and algorithms for retrievalintegrationcorrelationanalysis and interpretation of genomic datasequencing data and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes; providing information in the fields of life sciencesbiotechnologybioinformatics

Classe 44

Medical consulting services for the retrievalintegrationcorrelationanalysis and interpretation of genomicsequencing and molecular datadiseasesbiomarkersdrug protocolsdrug interactionsclinical profilesmedical and health informationrecords or datapatient specific datamolecular test resultsdata from clinical studiesscientific research for medical diagnostic and treatment purposes; providing online databases containing medicalpharmaceuticalbiologicalclinicalmolecularsequencing and genomic informationdisease informationbiomarker information and medical or health information or records about or relating to humans and patient specific datamolecular test resultsscientific research for medical diagnostic and treatment purposes; medical consulting services in the fields of healthmedical carebiotechnologybioinformaticslife sciencespharmaceuticals and medicine; providing information in the fields of healthhealthcarepharmaceuticals and pharmaceutical safetygenetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing pharmaceutical informationincluding information about drug safety and drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols

Publicações

Histórico de despachos e eventos da marca no USPTO.

61 publicações encontradas

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

13/07/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

13/07/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/06/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/06/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

25/05/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

25/05/2021

ALIE

ASSIGNED TO LIE

25/05/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

22/02/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

21/08/2020

GNRT

NON-FINAL ACTION E-MAILED

21/08/2020

CNRT

SU - NON-FINAL ACTION - WRITTEN

21/08/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

31/07/2020

IUAF

USE AMENDMENT FILED

10/07/2020

EISU

TEAS STATEMENT OF USE RECEIVED

10/07/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

15/01/2020

EX5G

SOU EXTENSION 5 GRANTED

14/01/2020

EXT5

SOU EXTENSION 5 FILED

09/01/2020

EEXT

SOU TEAS EXTENSION RECEIVED

09/01/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

13/07/2019

EX4G

SOU EXTENSION 4 GRANTED

11/07/2019

EXT4

SOU EXTENSION 4 FILED

11/07/2019

EEXT

SOU TEAS EXTENSION RECEIVED

11/07/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

15/01/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/01/2019

EX3G

SOU EXTENSION 3 GRANTED

11/01/2019

EXT3

SOU EXTENSION 3 FILED

11/01/2019

EEXT

SOU TEAS EXTENSION RECEIVED

11/01/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

13/07/2018

EX2G

SOU EXTENSION 2 GRANTED

11/07/2018

EXT2

SOU EXTENSION 2 FILED

11/07/2018

EEXT

SOU TEAS EXTENSION RECEIVED

11/07/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/07/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

21/02/2018

EX1G

SOU EXTENSION 1 GRANTED

20/02/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

20/02/2018

NREV

NOTICE OF REVIVAL - E-MAILED

05/02/2018

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

05/02/2018

PETG

PETITION TO REVIVE-GRANTED

05/02/2018

PROA

TEAS PETITION TO REVIVE RECEIVED

05/02/2018

EXT1

SOU EXTENSION 1 FILED

11/01/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/07/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

16/05/2017

PUBO

PUBLISHED FOR OPPOSITION

16/05/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

26/04/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/04/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/04/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/04/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/04/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

27/03/2017

GNRT

NON-FINAL ACTION E-MAILED

27/03/2017

CNRT

NON-FINAL ACTION WRITTEN

27/03/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

15/03/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

15/03/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

15/03/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

16/09/2016

GNRT

NON-FINAL ACTION E-MAILED

16/09/2016

CNRT

NON-FINAL ACTION WRITTEN

16/09/2016

DOCK

ASSIGNED TO EXAMINER

08/09/2016

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

02/06/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/06/2016

NWAP

NEW APPLICATION ENTERED

27/05/2016

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace MH MOLECULAR HEALTH ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.